|
|
|||||||||||
The British Journal of Psychiatry 140: 19-22 (1982)
© 1982 The Royal College of Psychiatrists
GE Hardy and JA Cotterill
Measures of depression and obsessionality were made in patients with dysmorphophobia, psoriasis and control subjects. The depression score distinguished all three groups. Patients with dysmorphophobia had significantly higher scores compared to the patients with psoriasis, who in turn had significantly higher scores compared to a control group. Patients with dysmorphophobia and psoriasis had equally elevated obsessional symptom scores compared to controls. It is unlikely, therefore, that dysmorphophobic symptoms are due to an obsessional state. Depression, however, was found to be an important clinical feature of dysmorphophobia.
This article has been cited by other articles:
![]() |
S. R. Rapp, M. L. Exum, D. M. Reboussin, S. R. Feldman, A. Fleischer, and A. Clark The Physical, Psychological and Social Impact of Psoriasis J Health Psychol, October 1, 1997; 2(4): 525 - 537. [Abstract] [PDF] |
||||
![]() |
F. Neziroglu and J. A. Yaryura-Tobias A Review of Cognitive Behavioral and Pharmacological Treatment of Body Dysmorphic Disorder Behav Modif, July 1, 1997; 21(3): 324 - 340. [Abstract] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |